Life Sciences Law

Lexis®PSL Life Sciences is an online practical guidance product for contentious and non-contentious lawyers providing advice to and supporting the UK’s Life Sciences sector.

Our content is written and structured to cover each stage in the life-cycle of a Life Sciences product from research and development to manufacturing, marketing and sale, including analyses of sector specific IP and data protection issues.

Our practice notes set out key principles supported by relevant authority and links through to in-depth commentary and underlying sources in Lexis®Library, all of which are designed to speed up the task of advising in this fast-moving and innovative sector.

LexisPSL Life Sciences is supported by an in-house legal team with extensive experience in practice and dedicated to producing content specifically for busy practitioners. This experience, combined with extensive customer research, has shaped our practical guidance on issues affecting the UK’s Life Sciences sector. We have built and continue to develop our product with the assistance of leading experts in the field.

Read moreread title

View Life Sciences by content type:

Latest Life Sciences News

Featured Life Sciences content

Practice notes
A director who is in any way, directly or indirectly, interested in:•a proposed transaction or arrangement with the company of which they are a...
Read More >
9th Nov
Practice notes
In order to establish that an unauthorised use or dealing in a product or process amounts to infringement of a patent it is necessary to prove that:•a...
Read More >
9th Nov
Practice notes
This Practice Note provides an introduction to arbitration and its key features, with a particular focus on arbitration under the law of England and...
Read More >
Produced in partnership with Simmons & Simmons LLP 12th Jan
Practice notes
Brexit: The UK's departure from the EU on exit day, ie Friday 31 January 2020, has implications for practitioners considering applicable law. For...
Read More >
9th Nov
Practice notes
An intellectual property (IP) owner may choose to license its IP to a third party. This can be an effective route to generating revenue while...
Read More >
Produced in partnership with Jessica Stretch 12th Jan
Practice notes
This Practice Note provides an introduction to retained EU law, which is an entirely new legal concept introduced to UK domestic law in preparation...
Read More >
9th Nov
Practice notes
As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an...
Read More >
9th Nov
Practice notes
Brexit: The UK's departure from the EU on exit day ie Friday 31 January 2020 has implications for practitioners considering the use of ADR as it may...
Read More >
9th Nov
Practice notes
Introduction to infringementA patent owner has to prove two elements before it can secure an infringement finding (and then an injunction, damages,...
Read More >
9th Nov
Practice notes
As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an...
Read More >
9th Nov
Precedents
Option 1—deed executed by a company under its common seal (model articles, where the authorised signatory is an...
Read More >
9th Nov
Precedents
1 Intellectual property rights indemnity 1.1 The Supplier shall defend the Customer against any third party claim that...
Read More >
9th Nov
Practice notes
Brexit: The UK's departure from the EU on exit day, ie Friday 31 January 2020, has implications for practitioners considering applicable law. For...
Read More >
9th Nov
Precedents
Month means a calendar month; Close This is a suggested definition for the term 'month', which...
Read More >
9th Nov

Most recent Life Sciences content

Practice notes
IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the UK’s...
Read More >
15th Jan
Practice notes
IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the UK’s...
Read More >
15th Jan
Precedents
Strictly private and confidentialTo: [insert buyer name][insert buyer address]Date: [insert date]Dear [insert buyer contact name],Proposed acquisition...
Read More >
15th Jan
Precedents
Strictly private and confidentialTo: [insert buyer name][insert buyer address]Date: [insert date]Dear [insert buyer contact name],Proposed acquisition...
Read More >
15th Jan
Precedents
IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the UK’s...
Read More >
15th Jan
Precedents
IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the UK’s...
Read More >
15th Jan
Precedents
IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the UK’s...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in France published as part of the Lexology Getting the...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Turkey published as part of the Lexology Getting the...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Iceland published as part of the Lexology Getting the...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in USA published as part of the Lexology Getting the Deal...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in United Arab Emirates published as part of the Lexology...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Mexico published as part of the Lexology Getting the...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in India published as part of the Lexology Getting the Deal...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Japan published as part of the Lexology Getting the Deal...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Germany published as part of the Lexology Getting the...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Russia published as part of the Lexology Getting the...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in China published as part of the Lexology Getting the Deal...
Read More >
15th Jan
Practice notes
This Practice Note contains a jurisdiction-specific Q&A guide to pharmaceutical trademarks in Pakistan published as part of the Lexology Getting the...
Read More >
15th Jan
Practice notes
Jurisdictions coveredThe following jurisdictions are covered in this report:China; France; Germany; Iceland; India; Japan; Mexico; Pakistan; Russia;...
Read More >
15th Jan

Popular documents